Own experience of primary mediastinal B-large cell lymphoma treatment

Own experience of primary mediastinal B-large cell lymphoma treatment

Due to the relative low incidence of primary mediastinal B-large cell lymphoma (PM BLCL) optimal approaches to its treatment is still not well developed. Possibility to improve PM BLCL clinical outcomes by intensifying induction chemotherapy (CT) and the use of rituximab, the usefulness of high-CT w...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. A. Vernyuk, N. G. Tyurina, O. A. Pavlova, A. M. Chervontseva, N. V. Zhukov
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Онкогематология
Subjects:	primary mediastinal b-large cell lymphoma macop-b rituximab autologous stem cell transplantation
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/14
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Primary mediastinal large B-cell lymphoma
by: L. A. Mazurok, et al.
Published: (2022-11-01)

OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT
by: Ulrike Bacher, et al.
Published: (2023-04-01)

Current trends in pediatric aggressive B-cell lymphomas treatment
by: Yu. S. Korkina, et al.
Published: (2021-06-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA
by: Ya. K. Mangasarova, et al.
Published: (2018-05-01)

Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience
by: TT Valiev, et al.
Published: (2016-10-01)

Primary mediastinal large B-cell lymphoma with a rare <i>ALK</i> gene mutation
by: O. I. Kit, et al.
Published: (2022-06-01)

Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Diagnostics of Extramediastinal Lesions and Treatment Opportunities
by: YaK Mangasarova, et al.
Published: (2018-07-01)

Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Experience in Treating 131 Patients at a National Medical Research Center in Russia
by: IZ Zavodnova, et al.
Published: (2018-12-01)

Primary Mediastinal (Thymic) Large B-Cell Lymphoma
by: GS Tumyan, et al.
Published: (2017-01-01)

Primary diffuse large B-cell lymphoma of the breast: Treatment and long-term outcome of two cases
by: Rajesh Kashyap, et al.
Published: (2020-01-01)

TRANSFORMATION OF FOLLICULAR LYMPHOMA INTO DIFFUSE LARGE B-CELL LYMPHOMA AFTER A DECADE OF REMISSION: A CASE REPORT
by: Elif Canpolat Hırfanoğlu, et al.
Published: (2025-07-01)

Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma
by: Mohammad Ma'koseh, et al.
Published: (2025-12-01)

Shorting of existing conditioning regimen for relapsed/refractory gastric diffuse large B-cell lymphoma transplant and studying its related outcomes: A first of its kind case report
by: Priyatesh Chandra Dwivedi, et al.
Published: (2025-01-01)

A randomized, multiple-dose, multicenter, comparative parallel study to evaluate the safety and efficacy of intravenous infusion of rituximab (Hetero) and reference medicinal product (Rituximab, Roche) in Indian patients of non-hodgkin's lymphoma (HERILY)
by: Suresh Advani, et al.
Published: (2018-01-01)

Treatment of central nervous system lymphoma — literature review and own experiences
by: S. V. Minenko, et al.
Published: (2014-07-01)

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2<sup>nd</sup> line treatment before autologous hematopoietic stem cell transplantation (preliminary results)
by: A. A. Mamedova, et al.
Published: (2022-07-01)

Primary diffuse large B-cell lymphoma of the central nervous system (case report and literature review)
by: K. A. Komratova, et al.
Published: (2017-04-01)

Cyclosporine combined with eltrombopag for treatment of secondary graft failure after autologous hematopoietic stem cell transplantation
by: S. V. Semochkin, et al.
Published: (2024-09-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

Rearrangement of Immunoglobulin Genes in Tumor Cells of Patients with Primary Mediastinal (Thymic) Large B-Cell Lymphoma
by: YaK Mangasarova, et al.
Published: (2019-05-01)

Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review
by: M. A. Mingalimov, et al.
Published: (2024-04-01)

Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies
by: Allison M. Bock, et al.
Published: (2025-07-01)

Role of high-dose chemotherapy with hemopoietic stem cell transplantation in patients with non-Hodgkin's lymphomas
by: V. V. Ptushkin, et al.
Published: (2022-11-01)

Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality
by: Alejandra Adriana Cardoso de Castro, et al.
Published: (2025-01-01)

Predictive levels of vascular endothelial growth factor (VEGF), thymidine kinase 1 (TK1) with interleukin-6 (IL-6), plasma T cells, NK cells as well as B cells in treating diffuse large B-cell lymphoma receiving rituximab
by: Tian Lihua, et al.
Published: (2025-01-01)

Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status
by: R. K. Karakulov, et al.
Published: (2022-01-01)

Chidamide plus R‐GDP for relapsed/refractory diffuse large B‐cell lymphoma in patients ineligible for autologous transplantation: A prospective, single‐arm, phase II study
by: Guang‐Liang Chen, et al.
Published: (2024-08-01)

Quality of life before autologous stem cells transplantation as prognostic factor in patients with malignant lymphomas
by: Yu. L. Shevchenko, et al.
Published: (2014-07-01)

Mitoxantrone‐Based Novel Conditioning Regimen Leads to Great Survival Benefit in Peripheral T‐Cell Lymphoma Compared to BEAM Regimen
by: Xinyu Zuo, et al.
Published: (2024-12-01)

Treatment of primary central nervous system lymphomas
by: I. V. Cherkashina, et al.
Published: (2021-06-01)

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements
by: Gabriela Piñero-Crespo, BS, et al.
Published: (2025-01-01)

Superior vena cava syndrome mimicking an allergic angioedema: a diagnostic odyssey from allergic reaction to mediastinal B-cell lymphoma
by: Simone Burgener-Enderli, et al.
Published: (2025-07-01)

Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study
by: Irene Dogliotti, et al.
Published: (2024-07-01)

A rare case of CD20− primary cutaneous diffuse large B-cell lymphoma, leg type
by: Juliette M. Kersten, MD, et al.
Published: (2024-12-01)

Consolidation therapy impact on survival outcomes in young patients with intracranial primary diffuse large B-cell lymphoma achieving complete remission: a propensity score matching analysis
by: Ge Wen, et al.
Published: (2025-03-01)

Non-Germinal Center Diffuse Large B-Cell Lymphoma of the Liver in a Renal Transplant Patient: A Case Report
by: Zohaib Ahmed, et al.
Published: (2025-06-01)

Primary Mediastinal Large B-cell Lymphoma – A Case Report
by: Bruno Pelinson Fogaça Duarte, et al.
Published: (2024-01-01)

Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India
by: Narendran Krishnamoorthi, et al.
Published: (2025-02-01)

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA
by: V. G. Potapenko, et al.
Published: (2017-01-01)